OncoGenomX

OncoGenomX

OncoGenomX (OGX) – ProVision of MammaLogX, a PM&L Powered Web Solution, designed for the Needs and Expectations of Women with Breast Cancer & Care Providers, Enabling Improved Outcome and Reduction of Costs, at the Benefit of All! Detail OnocoGenomX was co-founded in 2019 by Wolfgang Hackl, MD, clinical & translational research doctor & business professional, and David Demanse, MSc, a renowned pioneer of AI- and clinical/biologic inference modeling. OncoGenomX is a Swiss start-up in the accelerator phase. We pride ourselves in building a company culture around ambition, collaboration, optimism and fun. Our team is international, multidisciplinary with incredible talent in oncology, AI modeling & big data analytics, business and marketing. Presented by: Wolfgang Hackl

Presentation
Download (3 MB)
Innovation Description
Download (2 MB)

Contact

Address






Phone
E-mail: hacklwo@oncogenomx.com
Imprint